Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
3% diquafosol after pterygium surgery
ChiCTR1900026901Phase 4Recruiting
- Sponsor
- Zhongshan Ophthalmic Center
- Start
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of diquafosol and sodium hyaluronate in pterygium (2 arms), sponsored by Zhongshan Ophthalmic Center. Primary endpoints: Ocular surface index, Tear film examination and 2 more. Started Nov 2019; status: recruiting.
02
Drugs
diquafosolsodium hyaluronate
03
Conditions
pterygium
Beyond the preview
Go deeper on ChiCTR1900026901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900026901.